Fluicell is a public biotech company providing platforms to investigate cell behavior like never before. The company is a world leader and pioneer in open-volume microfluidics for the life sciences, and holds a strong IP and patent position with five different patent families in the estate.
Our graphic design and scientific illustration team explains with highly detailed and crafted drawings how Biopixlar® works to build a tissue model by printing one cell at the time in order to reproduce the complex composition of human tissues, the bioprinting techniques also need to enable printing cells in a precise and controlled manner.
BIOPIXLAR – A scientific illustration
In this case the graphic design for scientific illustration allows the company to show its technology at a glance in one single image and it also grabs the attention of the users in its corporate website.
Our scientific illustration solution can be also embedded into powerpoint presentations, websites and pdf´s documents for mobile devices.
Fluicell has developed Biopixlar, a game-changing bioprinting platform capable of producing tissue models by printing at the level of individual cells without a need of gel matrix. This gives possibilities to create complex tissues, just as they appear in nature, with different cell types and controlled histology optimized for your applications.
BIOPIXLAR – The unique high-resolution bioprinting platform
The platform includes high-resolution camera and fluorescence microscopy enabling real time monitoring of the printing process. Printing is performed in native cell media, maintaining cell viability and offering direct access for testing drugs.
How to use BIOPIXLAR®?
Place the Biopixlar printerhead at a desired spot, and print your cells of interest. The recirculating microfluidic technology enables direct cell patterning and printing, ranging from arrays of single cells to highly complex motifs with multiple cell types. After printing, the cell print is transferred to a cell culture platform allowing for the development of continuous and robust tissue models.